M3-Lectur2 Flashcards
Fetal Brain and HPA Axis
Exposures at critical windows of development can alter vulnerability (or resistance) to disease
True
Hypothalamic-pituitary-adrenal cortex (HPA) axis Neuroendocrine system
Controls synthesis of glucocorticoids:
Steroid hormones (“stress hormones”)
Humans: cortisol, cortisone (inactive)
Rodents: corticosterone, cortisone
How does the HPA axis work:
Stimulus activates neurosecretory (CRH) neurons in the PVN of the hypothalamus - signal anterior pituitary gland to release ACTH by stimulating expression of POMC (precursor to ACTH) - ACTH travels in blood to adrenal cortex and GC secretion
Note: GC inhibit their activity by negative feedback via GR hippocampus, PVN and anterior pituitary & via MR in hippocampus.
Glucoroticoids can cross membrane:
True
Enzyme that converts cortisol to inactive cortisone:
Hydroxysteriod dehydrogenase 2 (11beta-HSD2)
GU binds to either GR or mineralcorticoids receptor (MR) - higher affinity
These receptors are found in the cytoplasm.
Yes
GC can enter the nucleus and bind GRE, regulating transcription of certain genes, affecting metabolism, immune response, stress adaptation:
Yes
GC function:
Mediate stress response (“Fight or flight”)
Regulates energy and metabolism
Cardiovascular regulation
Modulates immune system, inflammation
Emotions and mood
Reproductive and developmental hormone
GCs function gestation:
Provide critical signal for organ maturation required for survival after birth.
Accretion and differentiation
GCs provide critical signals for timing of parturition:
Yes
Two ways of inducing labor:
- Fetal genome - fetal growth - Uterine stretch } Uterine growth that lead to activation of ion channels, gap junctions, Agonist receptor
- Fetal Genome - HPA axis - cortisol - placental endocrine Axis (p to E) that lead to stimulation of oxytocin, stimulatory, prostaglandins
Glucocorticoids (GC) like cortisol come from both the maternal and fetal HPA axes, playing essential roles in pregnancy.
Maternal HPA axis (direct): release cortisol in response to stress & physiological needs. It can then cross the placenta and influence fetal development.
Fetal HPA axis (direct): Fetus develops its own HPA axis, leading to production of cortisol. Prepares the fetus for birth.
Feedforward mechanism: Maternal cortisol stimulate release of CRH from placenta - activate fetal HPA axis - more cortisol from the fetus. Ensures both maternal and fetal systems respond appropriately.
As the fetal HPA axis is developing, so is the placenta
True
Placenta CRH synthesis and secretion ↑ = Increased circulating [cortisol]
Yes
Fetus protected from ↑ [cortisol] by function of placental 11β-HSD-2
Yes
Placental 11β-HSD-2 converts cortisol to inactive cortisone
due to:
15% maternal cortisol crosses unmetabolized
Cortisol levels in the fetal circulation are kept ~10-fold lower than the maternal circulation
- to prevent effects of high cortisol (maternal and also fetal cortisol)
True
to protect the fetus from excessive levels of cortisol
11BHSD-1 (converts cortisone to cortisol)
Yes
Overexposure or exposure of GC at inappropriate times during fetal development may modify:
Fetal HPA axis function
Brain development
Fetoplacental growth
Endocrine and metabolic function after birth
Causes of GC exposure:
Pre-term birth prevention:
Synthetic glucocorticoids like dexamethasone and betamethasone to promote fetal lung maturity & reduce incidence of respiratory distress syndrome.
Prenatal Stress Exposure:
Maternal stress can lead to more GC levels impacting fetal development.
Consequences of GC exposure:
Fetal deve.:
1. LBW, impaired neurodeve., high risk of behav. issues.
- Reduces inflammation & help manage complications with pregnancy.
Risks: Hypertension, metabolic disorders, and high susceptibility to infections.
- Neurodeve effect:
Exposure to elevated levels of glucocorticoids whether from maternal and synthetic can have long-term effect.
Synthetic glucocorticoids like dexamethasone and betamethasone are preferred over natural cortisol because they are more potent, have a longer duration of action, reduced mineralocorticoid effects, and allow for better control over dosing and therapeutic outcomes.
True
Causes of Preterm Birth:
Idiopathic (45-50%): Often multifactorial, including genetics, environmental factors, socioeconomic status, and maternal behaviors.
Preterm Premature Rupture of Membranes (PPROM) (30%): Often linked to infection or inflammation.
Medically Indicated (15-20%): Due to maternal health issues, fetal growth restriction, or congenital anomalies.
Readily cross the placenta as synthetic GCs are poor substrates for 11β-HSD-2
True
Consequences of SGCs (Long Term Outcomes)
sGCs showed no significant differences in body size, blood lipids, blood pressure, plasma cortisol, or the onset of diabetes and cardiovascular disease;
but participants showed increased plasma insulin levels and decreased glucose levels during oral glucose tolerance tests, indicating a potential risk for insulin resistance.
Another study found no improvements in outcomes with multiple courses of sGCs, showed significant reduction in birth weight, body length, & head circumstances
No diff. in risk of death or neurological impairment.
True